Evening oral insulin (ORMD-0801) glycaemic effects in uncontrolled type 2 diabetes patients

被引：0
|
作者：
Eldor, R. [1 ]
Fleming, A. [2 ]
Neutel, J. [3 ]
Homer, K. [4 ]
Kidron, M. [5 ]
Rosenstock, J. [6 ]
机构：
[1] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
[2] Kinexum, Harpers Ferry, WV USA
[3] Orange Cty Heart Inst & Res Ctr, Tustin, CA USA
[4] Integrium LLC, Tustin, CA USA
[5] Oramed Pharmaceut, Jerusalem, Israel
[6] Dallas Diabet Res Ctr, Dallas, TX USA
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
60
引用
下载
收藏
页码：S30 / S31
页数：2
相关论文
共 50 条
  • [1] Evening Oral Insulin (ORMD-0801) Glycemic Effects in Uncontrolled T2DM Patients
    Eldor, Roy
    Fleming, G. Alexander
    Neutel, Joel
    Homer, Kenneth E.
    Kidron, Miriam
    Rosenstock, Julio
    DIABETES, 2020, 69
  • [2] Oral Insulin (ORMD-0801) Effects on Glucose Parameters in Uncontrolled T2DM on OADs
    Eldor, Roy
    Fleming, G. Alexander
    Neutel, Joel
    Homer, Kenneth E.
    Kidron, Miriam
    Rosenstock, Julio
    DIABETES, 2020, 69
  • [3] Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study
    Eldor, Roy
    Arbit, Ehud
    Corcos, Asher
    Kidron, Miriam
    PLOS ONE, 2013, 8 (04):
  • [4] Efficacy and safety of 28-day treatment with oral insulin (ORMD-0801) in patients with type 2 diabetes: A randomized, placebo-controlled trial
    Eldor, Roy
    Neutel, Joel
    Homer, Kenneth
    Kidron, Miriam
    DIABETES OBESITY & METABOLISM, 2021, 23 (11): : 2529 - 2538
  • [5] Oral insulin (ORMD-0801) in type 2 diabetes mellitus: A dose-finding 12-week randomized placebo-controlled study
    Eldor, Roy
    Francis, Bruce H. H.
    Fleming, Alexander
    Neutel, Joel
    Homer, Kenneth
    Kidron, Miriam
    Rosenstock, Julio
    DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 943 - 952
  • [6] Multiple Oral Insulin (ORMD-0801) Doses Elicit a Cumulative Effect on Glucose Control in T2DM Patients
    Eldor, Roy
    Neutel, Joel
    Homer, Kenneth E.
    Kidron, Miriam
    DIABETES, 2018, 67
  • [7] Comparative Assessment of the Glucose-Lowering Effect of Multiple Oral Insulin (ORMD-0801) Formulation Variants in Pigs
    Kidron, Miriam
    Arbit, Ehud
    Shushlav, Yael
    DIABETES, 2014, 63 : A612 - A612
  • [8] The Glucose-Reducing Effect of Oral Insulin (ORMD-0801) vs. Placebo Treatment in T2DM Patients
    Kidron, Miriam
    Homer, Kenneth
    Neutel, Joel
    DIABETES, 2017, 66 : A257 - A257
  • [9] Preprandial Oral Insulin (ORMD-0801) Reduces Rapid-Acting Insulin Requirements and Fasting Glucose Levels in T1DM Patients
    Kidron, Miriam
    Neutel, Joel M.
    Arbit, Ehud
    DIABETES, 2015, 64 : A271 - A271
  • [10] Insulin degludec is superior to sitagliptin in improving glycaemic control in uncontrolled patients with type 2 diabetes on oral agents
    Philis-Tsimikas, A.
    Del Prato, S.
    Satman, I.
    Bhargava, A.
    Dharmalingam, M.
    Skjoth, T. V.
    Rasmussen, S.
    Garber, A. J.
    DIABETOLOGIA, 2012, 55 : S22 - S22
12345